Assertio Holdings, Inc. Announces Leadership Transition
January 03, 2024 08:59 ET
|
Assertio Holdings, Inc.
Dan Peisert Stepping Down as CEO Board member Heather Mason Appointed Interim CEO LAKE FOREST, Ill., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the...
Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors
November 14, 2023 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company that acquires, commercializes and...
Assertio Reports Third Quarter 2023 Financial Results
November 08, 2023 16:01 ET
|
Assertio Holdings, Inc.
Closed Spectrum Acquisition on July 31, 2023, which diversifies and extends portfolio duration Cash balance at September 30, 2023 of $76.9 million Announces Management Updates LAKE FOREST, Ill., Nov....
Assertio Holdings, Inc. to Release Third Quarter 2023 Financial Results on November 8, 2023
November 02, 2023 12:06 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 06, 2023 16:30 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
August 25, 2023 16:05 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to...
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
August 08, 2023 16:45 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to...
Assertio Reports Second Quarter 2023 Financial Results, Closes Spectrum Acquisition
August 03, 2023 16:04 ET
|
Assertio Holdings, Inc.
Second Quarter Net Product Sales Increase 13% Year-Over-Year, Generates $18.6 Million in Cash Flow from Operations Acquisition Expected to be Significantly Accretive to Adjusted EPS in 2024 LAKE...
Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction
July 31, 2023 19:27 ET
|
Assertio Holdings, Inc.
Combination of Assertio’s Omni-Channel Digital Sales Capabilities and ROLVEDON In-Person Commercial Team to Enhance Market Access and Growth Across All Products Transaction Expected to be...
Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals
July 27, 2023 16:01 ET
|
Assertio Holdings, Inc.
Stockholders From Both Assertio and Spectrum Have Overwhelmingly Voted in Support of the Transaction Transaction Expected to be Significantly Accretive to Assertio in 2024 LAKE FOREST, Ill. and...